InvestorPlace - Stock Market News, Stock Advice & Trading Tips
While Salarius Pharmaceuticals encountered a hiccup in its genomics research, the possibility of new funding may have lifted SLRX stock.
The post Why Is Salarius Pharmaceuticals (SLRX) Stock Up 90% Today? appeared first on InvestorPlace.
More From InvestorPlace